Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Novartis launches YouTube cancer talk show

Each Voice Counts forms part of firm’s existing advanced breast cancer initiative
Novartis YouTube advanced breast cancer talk show

Novartis is using YouTube to broadcast a new talk show about advanced breast cancer as part of its ongoing disease awareness efforts in the area.

The first episode of its Each Voice Counts talk show series features four women sharing their stories of life with the condition.

Novartis' key product in the area is Afinitor (everolimus), which gained European approval for advanced breast cancer in July, just days after US regulators passed it for the same indication.

The Each Voice Counts talk show follows the re-launch last week of Novartis' global AdvancedBreastCancerCommunity.org website.

The website is a collaboration between Novartis and Inspire, which builds and manages online support communities for patients and carers.

Advanced Breast Cancer Community offers a 'clearing house' of tailored information, covering topics such as creating a personal care plan and metastasis and recurrence.

Novartis' use of YouTube for videos in a talk show format, though unusual, is not unique, and has echoes of the Johnson & Johnson's employee video series ennTV, which debuted in April and the New Way RA talk show it began in 2009.

9th October 2012

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics